Cingulate Inc. Alternatives & Competitors

12 companies similar to Cingulate Inc. — Innovative drug delivery technology for next-generation therapeutics.

Ception Therapeutics, Inc.

Ception Therapeutics, Inc. is a biotechnology company based out of Malvern, Pennsylvania

6 Series C $77.70M

Malvern, United States

Biotechnology Health Care +1

Omeros Corporation

Let science lead the way

234 Grant $819.98M

Seattle, United States

Biotechnology Health Care +1

Otonomy, Inc

11 Post-IPO Equity $498.01M

San Diego, United States

Biopharma Biotechnology +1

Sciwind Biosciences

Pioneering treatments to empower physicians in addressing metabolic disorders with advance...

1 Series C $307.00M

Biotechnology Health Care +1

Track all Cingulate Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Sopherion Therapeutics

Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.

Series C $163.00M

Biotechnology Health Care +1

IntelGenx Corp.

Leader in pharmaceutical films

39 Post-IPO Equity $6.50M

Saint-laurent, Canada

Biotechnology Health Care +1

Lyndra Therapeutics

What if we stopped trying to change the patient and changed the pill instead?

85 Series E $284.63M

Watertown, United States

Biotechnology Health Care +1

Ophidion

Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...

Convertible Note $1.70M

Biotechnology Health Care +1

Elixirgen Therapeutics, Inc.

Reimagine the Power of RNA

13 Venture round $25.91M

Baltimore, United States

Biotechnology Health Care +1

SiSaf Ltd

Delivering on the promise of RNA therapeutics

19 Series B $21.83M

Guildford, United Kingdom

Biotechnology Health Care +1

Atlantic Healthcare

Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs wor...

Series B $62.00M

Biotechnology Health Care +1

Alzamend Neuro

Targeting treatment for Alzheimer's Disease, Major Depressive Disorder, Bipolar Disorder,...

9 Post-IPO Equity $25.00M

Atlanta, United States

Biotechnology Health Care

About Cingulate Inc.

Cingulate Inc. is a biopharmaceutical company with a mission to advance the field of therapeutics through its innovative Precision Timed Release™ (PTR) drug delivery platform technology. Founded in 2012, the company aims to address the challenges faced by patients with conditions that require burdensome daily dosing re...

Taxonomy

Biopharmaceutical, Drug Delivery Technology, Precision Timed Release, Therapeutics, ADHD, Anxiety Disorders, Pharmaceutical Products, Catalent Pharma Solutions, OptiDose Technology, Intellectual Property, Patents, Stimulants, Clinical Use, Patient Efficacy, Commercialization

Frequently Asked Questions

Companies similar to Cingulate Inc. include Ception Therapeutics, Inc., Omeros Corporation, Otonomy, Inc, Sciwind Biosciences, Sopherion Therapeutics. They work in Biotechnology and Health Care and share Cingulate Inc.'s focus on biopharmaceutical, intellectual property and therapeutics.

Bounce Watch lists 12 companies that share Cingulate Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Cingulate Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Cingulate Inc. Profile Ception Therapeutics, Inc. Alternatives Omeros Corporation Alternatives Otonomy, Inc Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Cingulate Inc. on 14 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 23 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.